Webinars

Register for upcoming (live) or recorded webinars, choose by topic, or search by keyword to find webinars of interest.

Pharmaceutical Regulation 

There are a wide range of topics covered under this listing of “regulatory webinars” – from current updates from the FDA and EMA and risk minimization procedures, to issues surrounding IRBs.

December 07, 2018

Reducing the eTMF Operational Burden Using Risk-Based Approaches
November 27, 2018

Developing Psychedelics Into Medicine: Potential and Pitfalls
November 21, 2018

Drug Development – The 6 Most Critical Reasons Why Drugs are Delayed When Planning and Conduc...
November 20, 2018

Drug Abuse Potential: A Data Analysis Strategy for Nonclinical Self-Administration Studies
November 13, 2018

Speed, Quality & Cost – Why You Should be Conducting Your Clinical Trials in Australia
November 08, 2018

How the 21st Century Cures Act and FDA Guidelines for Patient-Focused Drug Development Impact R...
October 18, 2018

How to Effectively Communicate with FDA Regulators
October 17, 2018

Quality In, Quality Out: Best Practices and Tools for Supplier Quality Management (Part 4 of 4)...
October 16, 2018

Routes to Improve Pediatric Patient Engagement in Clinical Trials
October 10, 2018

Interventional vs. Non-Interventional: Considerations for Correctly Classifying Your Clinical S...
October 03, 2018

Data Validity and Regulatory-Grade Real World Evidence
September 19, 2018

Quality In, Quality Out: Regulations Driving Pharmaceutical Supplier Quality Management (Part 3...
July 25, 2018

How the New FDA Drug-Drug Interaction Guidance Fits Within the Drug Development De-Risking Mode...
July 23, 2018

Industry Analysis: Impact of FDA’s Recent Guidance on Payer Communications
July 18, 2018

Quality In, Quality Out: Exploring Pharmaceutical and Medical Device Supplier Quality Managemen...